Pharmaceutical Stocks Get Boost from Swine Flu?
Filed under: Wealth
Pandemic spells profit for pharmaceutical giants like Sanofi-Aventis (SNY), GlaxoSmithKline (GSK) and Merck who represent the top three producers of vaccines to treat H1N1 or swine flu. A couple weeks ago the World Health Organization prepared to declare the first worldwide pandemic in four decades and with that news the aforementioned pharmaceutical stocks began to rise 1%-2.2% on the board. At that time 27,737 H1N1 infections had been reported across seventy-four countries including 141 deaths. Countries across the globe will be inclined to increase flu-vaccine stockpiles in the hopes of controlling the potential pandemic within their borders.When the bird flu, H5N1, was a pandemic threat a few years ago the mere production of an effective bird-flu vaccine paired with a successful clinical trial by GlaxoSmithKline impacted their second quarter positively with a 14% rise in net profits and an 11% rise in sales. At the time it was estimated that the H5N1 vaccine could potentially garner $2 million in annual sales for Glaxo. Impressive!
This just goes to show that not all stocks are in peril -- the human population may be, but that's another story.

Forbidden America: Cold War-Era Map Shows No-Go Zones For Soviet Tourists
Tenants: Stench of Death Makes St. Louis Complex 'Unlivable'
Chili's Waitress Fired Over Facebook Post Insulting 'Stupid Cops'
Man Takes Dump In Background Of Instructional Workout Video
Ricardo Cerezo, Facing Eviction, Finds $4.85 Million Lottery Ticket
2013 Billboard Music Awards: Arrivals Photos From the Blue Carpet!
MIT's cheetah robot runs faster, more efficiently, can carry its own power supply (video)
2013 Billboard Music Awards: All the Winners!
Forever 21 Worker Fired After She Tells Her Traumatic Story
Taylor Swift Q and A: What Does She Splurge on in Las Vegas?